GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca Pharma India Ltd (BOM:506820) » Definitions » Issuance of Stock

AstraZeneca Pharma India (BOM:506820) Issuance of Stock : ₹0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Pharma India Issuance of Stock?

AstraZeneca Pharma India's Issuance of Stock for the three months ended in Mar. 2024 was ₹0 Mil.

AstraZeneca Pharma India's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0 Mil.


AstraZeneca Pharma India Issuance of Stock Historical Data

The historical data trend for AstraZeneca Pharma India's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Pharma India Issuance of Stock Chart

AstraZeneca Pharma India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AstraZeneca Pharma India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AstraZeneca Pharma India Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AstraZeneca Pharma India Issuance of Stock Related Terms

Thank you for viewing the detailed overview of AstraZeneca Pharma India's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca Pharma India (BOM:506820) Business Description

Traded in Other Exchanges
Address
Outer Ring Road, Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Bangalore, KA, IND, 560 045
AstraZeneca Pharma India Ltd is engaged in the manufacture, distribution, and marketing of pharmaceutical products. Its only operating segment being Healthcare. The company generates revenue from the sale of products such as Tablets, Injectables, and Inhalation. Geographically, it derives a majority of revenue from India. It focuses on areas such as Cardiovascular, Renal and Metabolism (CVRM), Oncology, Respiratory, Inflammation and Autoimmunity, Neuroscience and Infection and Vaccines.

AstraZeneca Pharma India (BOM:506820) Headlines

No Headlines